PROTEUS SYNDROME
Clinical trials for PROTEUS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PROTEUS SYNDROME trials appear
Sign up with your email to follow new studies for PROTEUS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for rare overgrowth disease: first treatment trial
Disease control Recruiting nowThis study is testing whether a drug called miransertib can safely slow or stop the abnormal tissue overgrowth caused by Proteus syndrome, a rare and serious genetic condition. It will involve about 45 participants aged 3 and older who have a confirmed diagnosis. Participants wil…
Matched conditions: PROTEUS SYNDROME
Phase: PHASE2 • Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scientists seek genetic clues to rare overgrowth disorder
Knowledge-focused Recruiting nowThis study aims to learn more about Proteus syndrome, a rare condition that causes unusual and uneven growth of bones, skin, and other tissues. Researchers will observe up to 1,500 patients over time to understand the genetic causes, how symptoms change, and the disease's impact …
Matched conditions: PROTEUS SYNDROME
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC